Hoisnard L

ORCID: 0000-0002-0921-5142 · 4 papers in corpus
observational 2025
European journal of neurology ·doi:10.1111/ene.16505

BACKGROUND AND PURPOSE: Chlormadinone acetate (CMA) is a synthetic progestin for which cases of intracranial meningioma have been reported following prolonged exposure. METHOD: An observational cohort study was conducted based on the Frenc…

observational 2024
The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2024.100928

BACKGROUND: Nomegestrol acetate (NOMAC) is a synthetic potent progestogen. This study aimed to assess the risk of intracranial meningioma associated with the prolonged use of NOMAC. METHODS: Observational cohort study using SNDS data (Fran…

observational 2024
BMJ (Clinical research ed.) ·doi:10.1136/bmj-2023-078078

OBJECTIVE: To assess the risk of intracranial meningioma associated with the use of selected progestogens. DESIGN: National case-control study. SETTING: French National Health Data System (ie, Système National des Données de Santé). PART…

observational 2022
European journal of neurology ·doi:10.1111/ene.15423

BACKGROUND AND PURPOSE: A dose-dependent association between the use of cyproterone acetate (CPA) and intracranial meningioma has been identified but data for other potent progestogens are scarce. The association was assessed between intrac…